OptiNose Inc
NASDAQ:OPTN

Watchlist Manager
OptiNose Inc Logo
OptiNose Inc
NASDAQ:OPTN
Watchlist
Price: 9.6 USD -1.13%
Market Cap: 97.2m USD

Relative Value

The Relative Value of one OPTN stock under the Base Case scenario is hidden USD. Compared to the current market price of 9.6 USD, OptiNose Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

OPTN Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
71
vs Industry
70
Median 3Y
1.7
Median 5Y
2
Industry
2.7
Forward
0.9
vs History
vs Industry
Median 3Y
-3.3
Median 5Y
-2.9
Industry
21.5
Forward
-3.7
vs History
vs Industry
Median 3Y
-2.5
Median 5Y
-2.5
Industry
16.7
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
-2.1
Industry
23
vs History
vs Industry
3
Median 3Y
-2.4
Median 5Y
-2.4
Industry
2.3
vs History
73
vs Industry
61
Median 3Y
2.1
Median 5Y
2.8
Industry
2.9
Forward
1.4
vs History
73
vs Industry
74
Median 3Y
2.4
Median 5Y
3.2
Industry
5.6
vs History
vs Industry
Median 3Y
-7.2
Median 5Y
-5.4
Industry
13.2
Forward
226.4
vs History
vs Industry
Median 3Y
-7.1
Median 5Y
-5.3
Industry
16.6
Forward
-13.9
vs History
vs Industry
Median 3Y
-3.4
Median 5Y
-3.1
Industry
15.8
vs History
vs Industry
Median 3Y
-3.4
Median 5Y
-3.1
Industry
19
vs History
73
vs Industry
24
Median 3Y
4.9
Median 5Y
5.1
Industry
2

Multiples Across Competitors

OPTN Competitors Multiples
OptiNose Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
OptiNose Inc
NASDAQ:OPTN
96.6m USD 1.2 -4.5 -8.6 -8.5
US
Eli Lilly and Co
NYSE:LLY
1T USD 17 54.9 36.9 39.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
497.1B USD 5.4 19.8 16.2 21
CH
Roche Holding AG
SIX:ROG
261.4B CHF 4.2 27.7 11.8 13.8
UK
AstraZeneca PLC
LSE:AZN
211.6B GBP 4.9 30.3 108.4 158.7
CH
Novartis AG
SIX:NOVN
210.3B CHF 4.7 18.4 11.7 15.1
US
Merck & Co Inc
NYSE:MRK
263.1B USD 4.1 13.8 9.8 11.6
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK 4.6 14 9.8 11.4
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
142.9B USD 2.3 14.5 7.4 10.1
P/E Multiple
Earnings Growth PEG
US
OptiNose Inc
NASDAQ:OPTN
Average P/E: 24.2
Negative Multiple: -4.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.9
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.8
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.7
29%
1
UK
AstraZeneca PLC
LSE:AZN
30.3
37%
0.8
CH
Novartis AG
SIX:NOVN
18.4
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.8
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
14
3%
4.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.5
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
OptiNose Inc
NASDAQ:OPTN
Average EV/EBITDA: 439.7
Negative Multiple: -8.6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.9
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.8
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.4
10%
10.8
CH
Novartis AG
SIX:NOVN
11.7
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.8
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.8
1%
9.8
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
OptiNose Inc
NASDAQ:OPTN
Average EV/EBIT: 1 883.3
Negative Multiple: -8.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.5
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.8
6%
2.3
UK
AstraZeneca PLC
LSE:AZN
158.7
23%
6.9
CH
Novartis AG
SIX:NOVN
15.1
12%
1.3
US
Merck & Co Inc
NYSE:MRK
11.6
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
11.4
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.1
7%
1.4